Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.

Saudi J Gastroenterol · 2015 · PMC4707805 · PMID 26655132

Europe PMC DOI

hedged sentences

0.0400

closest p · 0.8× alpha

0.0400

boldest claim

The sentences

a slight significanceP = 0.04actually significant

After data were pooled from somatostatin trials, PEP occurred in 8.36% of controls versus 5.62% of the treated group, with a slight significance [relative risk (RR) =0.58, 95% confidence interval (CI) 0.35–0.98, P = 0.04].

also in 66 other papers

slightly significantP = 0.04actually significant

Seven of the 11 reports did not produce statistically significant results, and their pooled RR was slightly significant (RR = 0.58, 95% CI 0.35–0.98, P = 0.04) [ Figure 1 ].

also in 1,692 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.